Schedule 13D ownership disclosure

Emmaus Life Sciences, Inc.

Security class unavailable · CUSIP: 29137T101

Event date: 2020-02-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
25.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-20-008454
Form type
SC 13D/A
Filer
Emmaus Life Sciences, Inc.
CIK
CIK 822370
Filed
Apr 02, 2020
Reporting period
Feb 06, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub